{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:54:22Z","timestamp":1765810462690,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.7759\/cureus.99282","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:51:54Z","timestamp":1765810314000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeting COX-2 to Alleviate Depressive Phenotypes: Etoricoxib\u2019s Antidepressant Effects in Chronic Unpredictable Mild Stress-Exposed Mice"],"prefix":"10.7759","author":[{"given":"Santhanalakshmi","family":"P","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manimekalai","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathiyamoorthy","family":"P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi S","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, et al.. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007, 370:851-8. 10.1016\/S0140-6736(07)61415-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.12.014","article-title":"Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease","volume":"125","author":"Maes M","year":"2010","unstructured":"Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord. 2010, 125:287-94. 10.1016\/j.jad.2009.12.014","journal-title":"J Affect Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2011.07.015","article-title":"Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice","volume":"100","author":"Abdel-Wahab BA","year":"2011","unstructured":"Abdel-Wahab BA, Salama RH. Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice. Pharmacol Biochem Behav. 2011, 100:59-65. 10.1016\/j.pbb.2011.07.015","journal-title":"Pharmacol Biochem Behav"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-011-0232-0","article-title":"Is depression an inflammatory disorder?","volume":"13","author":"Raison CL","year":"2011","unstructured":"Raison CL, Miller AH. Is depression an inflammatory disorder?. Curr Psychiatry Rep. 2011, 13:467-75. 10.1007\/s11920-011-0232-0","journal-title":"Curr Psychiatry Rep"},{"key":"ref5","article-title":"Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma","volume":"51","author":"Friebe A","year":"2010","unstructured":"Friebe A, Horn M, Schmidt F, et al.. Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma. Psychosomatics. 2010, 51:466-73.","journal-title":"Psychosomatics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring S","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, et al.. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006, 367:29-35. 10.1016\/S0140-6736(05)67763-X","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.2.224","article-title":"Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers","volume":"31","author":"Rodrigues AD","year":"2003","unstructured":"Rodrigues AD, Halpin RA, Geer LA, et al.. Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers. Drug Metab Dispos. 2003, 31:224-32. 10.1124\/dmd.31.2.224","journal-title":"Drug Metab Dispos"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.03.010","article-title":"Depression and oxidative damage to lipids","volume":"35","author":"Yager S","year":"2010","unstructured":"Yager S, Forlenza MJ, Miller GE. Depression and oxidative damage to lipids. Psychoneuroendocrinology. 2010, 35:1356-62. 10.1016\/j.psyneuen.2010.03.010","journal-title":"Psychoneuroendocrinology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00232-012-9436-4","article-title":"Oxidative parameters in the rat brain of chronic mild stress model for depression: relation to anhedonia-like responses","volume":"245","author":"Wang C","year":"2012","unstructured":"Wang C, Wu HM, Jing XR, Meng Q, Liu B, Zhang H, Gao GD. Oxidative parameters in the rat brain of chronic mild stress model for depression: relation to anhedonia-like responses. J Membr Biol. 2012, 245:675-81. 10.1007\/s00232-012-9436-4","journal-title":"J Membr Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.03.076","article-title":"Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain","volume":"612","author":"Guo JY","year":"2009","unstructured":"Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol. 2009, 612:54-60. 10.1016\/j.ejphar.2009.03.076","journal-title":"Eur J Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi SH","year":"2012","unstructured":"Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012, 141:308-14. 10.1016\/j.jad.2012.03.033","journal-title":"J Affect Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh S","year":"2009","unstructured":"Akhondzadeh S, Jafari S, Raisi F, et al.. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009, 26:607-11. 10.1002\/da.20589","journal-title":"Depress Anxiety"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1159-5","article-title":"Antidepressant-like effect of celecoxib piroxicam in rat models of depression","volume":"121","author":"Santiago RM","year":"2014","unstructured":"Santiago RM, Barbiero J, Martynhak BJ, et al.. Antidepressant-like effect of celecoxib piroxicam in rat models of depression. J Neural Transm (Vienna). 2014, 121:671-82. 10.1007\/s00702-014-1159-5","journal-title":"J Neural Transm (Vienna)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2007000100015","article-title":"Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats","volume":"40","author":"Azoubel MC","year":"2007","unstructured":"Azoubel MC, Menezes AM, Bezerra D, Ori\u00e1 RB, Ribeiro RA, Brito GA. Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. Braz J Med Biol Res. 2007, 40:117-25. 10.1590\/s0100-879x2007000100015","journal-title":"Braz J Med Biol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-02932-0","article-title":"Therapeutic potential of COX-2 inhibitors in neuropsychiatric disorders","volume":"132","author":"Sharma V","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG. Therapeutic potential of COX-2 inhibitors in neuropsychiatric disorders. J Neural Transm (Vienna). 2025, 132:999-1011. 10.1007\/s00702-025-02932-0","journal-title":"J Neural Transm (Vienna)"},{"key":"ref16","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt RD","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants.  Arch Int Pharmacodyn Ther. 1977, 229:327-36.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3791\/52587","article-title":"The forced swim test as a model of depressive-like behavior","author":"Yankelevitch-Yahav R","year":"2015","unstructured":"Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. J Vis Exp. 2015, 10.3791\/52587","journal-title":"J Vis Exp"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2012.02.034","article-title":"Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice","volume":"682","author":"Girish C","year":"2012","unstructured":"Girish C, Raj V, Arya J, Balakrishnan S. Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol. 2012, 682:118-25. 10.1016\/j.ejphar.2012.02.034","journal-title":"Eur J Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2986090","article-title":"Antidepressant-like effect of lipid extract of channa striatus in chronic unpredictable mild stress model of depression in rats","volume":"2016","author":"Abdul Shukkoor MS","year":"2016","unstructured":"Abdul Shukkoor MS, Baharuldin MT, Mat Jais AM, Mohamad Moklas MA, Fakurazi S. Antidepressant-like effect of lipid extract of channa striatus in chronic unpredictable mild stress model of depression in rats. Evid Based Complement Alternat Med. 2016, 2016:2986090. 10.1155\/2016\/2986090","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.05.035","article-title":"Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats","volume":"499","author":"Wang Y","year":"2011","unstructured":"Wang Y, Yang F, Liu YF, Gao F, Jiang W. Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats. Neurosci Lett. 2011, 499:74-9. 10.1016\/j.neulet.2011.05.035","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-013-1664-0","article-title":"Chronic mild stress for modeling anhedonia","volume":"354","author":"Wiborg O","year":"2013","unstructured":"Wiborg O. Chronic mild stress for modeling anhedonia. Cell Tissue Res. 2013, 354:155-69. 10.1007\/s00441-013-1664-0","journal-title":"Cell Tissue Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.31024\/ajpp.2022.8.2.1","article-title":"Antidepressant effect of etoricoxib and ibuprofen on chronic mild stress-induced depression in mice","volume":"8","author":"Patel G","year":"2022","unstructured":"Patel G, Goswami S. Antidepressant effect of etoricoxib and ibuprofen on chronic mild stress-induced depression in mice. Asian J Pharma and Pharmacol. 2022, 8:36-45. 10.31024\/ajpp.2022.8.2.1","journal-title":"Asian J Pharma and Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-7634(05)80192-7","article-title":"Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis","volume":"16","author":"Muscat R","year":"1992","unstructured":"Muscat R, Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev. 1992, 16:507-17. 10.1016\/s0149-7634(05)80192-7","journal-title":"Neurosci Biobehav Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.06.008","article-title":"Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats","volume":"193","author":"Kompagne H","year":"2008","unstructured":"Kompagne H, B\u00e1rdos G, Sz\u00e9n\u00e1si G, Gacs\u00e1lyi I, H\u00e1rsing LG, L\u00e9vay G. Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats. Behav Brain Res. 2008, 193:311-4. 10.1016\/j.bbr.2008.06.008","journal-title":"Behav Brain Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.07.020","article-title":"Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression","volume":"33","author":"Dang H","year":"2009","unstructured":"Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2009, 33:1417-24. 10.1016\/j.pnpbp.2009.07.020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.01.006","article-title":"Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats","volume":"33","author":"Li YC","year":"2009","unstructured":"Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY, Kong LD. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009, 33:435-49. 10.1016\/j.pnpbp.2009.01.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref27","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation, and usage","author":"Willner P: . Neurobiology of stress. 2017;6:78-93","unstructured":"Willner P. . Neurobiology of stress. 2017;6:78-93: The chronic mild stress (CMS) model of depression: history, evaluation, and usage. Neuropsychobiology.","journal-title":"Neuropsychobiology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hup.178","article-title":"How valuable are animal models in defining antidepressant activity?","volume":"16","author":"Bourin M","year":"2001","unstructured":"Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining antidepressant activity?. Hum Psychopharmacol. 2001, 16:9-21. 10.1002\/hup.178","journal-title":"Hum Psychopharmacol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: a critical review","volume":"83","author":"Walsh RN","year":"1976","unstructured":"Walsh RN, Cummins RA. The Open-Field Test: a critical review. Psychol Bull. 1976, 83:482-504.","journal-title":"Psychol Bull"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms11125310","article-title":"Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor,","volume":"11","author":"Rong H","year":"2010","unstructured":"Rong H, Wang G, Liu T, et al.. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor,. Int J Mol Sci. 2010, 11:5310-22.","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.09.006","article-title":"Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis","volume":"48","author":"Na KS","year":"2014","unstructured":"Na KS, Lee KJ, Lee JS, Cho YS, Jung HY. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2014, 48:79-85. 10.1016\/j.pnpbp.2013.09.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439436-targeting-cox-2-to-alleviate-depressive-phenotypes-etoricoxibs-antidepressant-effects-in-chronic-unpredictable-mild-stress-exposed-mice","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:51:55Z","timestamp":1765810315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439436-targeting-cox-2-to-alleviate-depressive-phenotypes-etoricoxibs-antidepressant-effects-in-chronic-unpredictable-mild-stress-exposed-mice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.99282","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}